Synthesis and antimicrobial activity of 2-(acyl or carboxyalkyl)-3-(H or alkyl or aryl)-5 (or -6 or -8)-monochloro,7-fluoro-substituted-4H-1,4- benzothiazines

Journal of Heterocyclic Chemistry

Volumn 43, Issue 5, 2006, Pages 1371-1378

  Armenise, Domenico ^a   De Laurentis, Nicolino ^a   Rosato, Antonio ^a   Morlacchi, Flaviano ^a  

^a UNIVERSITY OF BARI   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

1 (5 CHLORO 7 FLUORO 3 METHYL 4H 1,4 BENZOTHIAZIN 2 YL)ETHANONE; 1 (5 CHLORO 7 FLUORO 4H 1,4 BENZOTHIAZIN 2 YL)ETHANONE; 1 (8 CHLORO 7 FLUORO 3 METHYL 4H 1,4 BENZOTHIAZIN 2 YL)ETHANONE; ALKYL GROUP; ANTIINFECTIVE AGENT; ASCORBIC ACID; BENZOTHIAZINE DERIVATIVE; CARBOXYL GROUP; FLUCONAZOLE; FLUORINE DERIVATIVE; POLYCYCLIC AROMATIC HYDROCARBON DERIVATIVE; UNCLASSIFIED DRUG;

ANTIBACTERIAL ACTIVITY; ANTIFUNGAL ACTIVITY; ANTIMICROBIAL ACTIVITY; ARTICLE; BACTERIAL STRAIN; CONTROLLED STUDY; DRUG SYNTHESIS; FUNGUS; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE BACTERIUM; IN VITRO STUDY; INFRARED SPECTROSCOPY; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PROTON NUCLEAR MAGNETIC RESONANCE; QUANTUM YIELD; REACTION ANALYSIS; STRUCTURE ACTIVITY RELATION;

EID: 33750982712     PISSN: 0022152X     EISSN: None     Source Type: Journal    
DOI: 10.1002/jhet.5570430536     Document Type: Article

References (17)

1. [1a] Shivanji B. Munde, Sandeep P. Bondge, Venkatesh E. Bhingolikar, Ramrao A. Mane, Green Chemistry, 5, 278-279 (2003);
2. [b] D. Armenise, G. Trapani, V. Arrivo, E. Laraspata, F. Morlacchi, J. Heterocyclic Chem., 37, 1611-1616 (2000);
3. [c] D. Armenise, G. Trapani, F. Stasi, F. Morlacchi, Arch. Pharm. Pharm. Med. Chem., 331, 54-58 (1998);
4. [d] G. Scapini, F. Duro, G. Pappalardo, Annali di Chimica, 58(10), 1058-1074 (1968);
5. [e] F. Duro, P. Condorelli, G. Scapini, G. Pappalardo, Annali di Chimica, 60(5), 383-392 (1970).
6. M. Y. Hamadi, R. Gupta, R. R. Gupta, J. of Fluorine Chem., 94, 169-174 (1999).
7. R. R. Gupta, Phenothiazines and 1,4-benzothiazines - Chemical and Biomedical Aspects, Elsevier, Amsterdam, Vol. 4, pp. 163-269 (1988).
8. T. Takizawa, J. Matsumoto, T. Tohma, T. Kanke, Y. Wada, M. Nagoo, N. Inogaki, H. Nagai, M. Zhang, H. Timmerman, Jpn. J. Pharmacol., 86(1), 55-64, (2001).
9. S. Y. Sheu, C. Y. Lin, J. D. Wu, H. C. Ching, Anticancer Research, 119-19(1A), 23 (1999).
10. V. Cecchetti, A. Fravolini, F. Schiaffella, O. Tabarrini, Weicheng Zhou, J. Heterocyclic Chem., 29, 375-382 (1992).
11. [7a] G. Trapani, A. Latrofa, M. Franco, D. Armenise, F. Morlacchi, Arzneim.- Forsch./Drug Res., 44 (II), 8, 969-971 (1994);
12. [b] D. Armenise, N. De Laurentis, A. Reho, A. Rosato, F. Morlacchi, J. Heterocyclic Chem., 41, 771-775 (2004).
13. V. Cecchetti, A. Fravolini, R. Fringuelli, G. Mascellani, P. Pagella, M. Palmioli, G. Segre, and P. Terni, J. Med. Chem., 30, 465-473 (1987).
14. th ed.). Approved standard M7-A6. Clinical and Laboratory Standard Institute, Wayne, PA: USA (2003).
15. th ed.). Suggested standard MIOO-S13. Clinical and Laboratory Standard Institute Wayne, PA: USA (2003).
16. th ed., American Society of Microbiology, (New York, USA) (1999).
17. nd ed.). Approved standard M27-A2. Clinical and Laboratory Standard Institute Wayne, PA: USA (2002).